Clinical trial
Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
NCT00443612 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00443612 |
|---|---|
| Title | Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing |
| Official title | A Randomized, Open Label, Cross-over Comparative Study of Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Irbesartan/Hydrochlorothiazide, Irbesartan |
| Enrollment | 60 |
| Start date | Sep 1, 2006 |
| Primary completion | Oct 1, 2008 |
| First posted | Mar 6, 2007 |
| Last update posted | Oct 1, 2009 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: